CFDE Data Portal | Search ADIPOQ

	Label	Description
	ADIPOQ associations Collection (Entity type)	Associations for ADIPOQ_associations
	ADIPOQ associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ADIPOQ-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	ADIPOQ-AS1 associations Collection (Entity type)	Associations for ADIPOQ-AS1_associations
	ADIPOQ Gene (Entity type)	ENSG00000181092 - adiponectin, C1Q and collagen domain containing
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE216043 7 V 9 CISPLATIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE102505 5 V 0 TUNICAMYCIN HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 14 V 13 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

ADIPOQ associations

Associations for ADIPOQ_associations

ADIPOQ associations.tsv

A file from IDG as part of the Harmonizome project

ADIPOQ-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

ADIPOQ-AS1 associations

Associations for ADIPOQ-AS1_associations

ADIPOQ

ENSG00000181092 - adiponectin, C1Q and collagen domain containing

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE216043 7 V 9 CISPLATIN HUMAN DN

A Gene Set from LINCS

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE102505 5 V 0 TUNICAMYCIN HUMAN DN

A Gene Set from LINCS

GSE233679 14 V 13 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.